A Japanese health ministry panel on Wednesday postponed a decision to approve the use of the oral COVID-19 drug "Xocova" developed by Shionogi & Co., the second time for the decision to be delayed following a meeting last month.The deferral by members of the Health, Labor and Welfare Ministry panel and their decision to continue discussions came amid concerns the Japanese pharmaceutical firm was unable to demonstrate the drug's efficacy in its clinical trials.The Pharmaceuticals and Medical Devices Agency had said it cannot be determined that the pill can be presumed effective, noting it wa…READ FULL ARTICLE
